Literature DB >> 8842044

The role of serum complement on the organ distribution of intravenously administered poly (methyl methacrylate) nanoparticles: effects of pre-coating with plasma and with serum complement.

G Borchard1, J Kreuter.   

Abstract

PURPOSE: The organ distribution of radiolabeled poly (methyl methacrylate) (PMMA) nanoparticles coated with plasma proteins and serum complement in rats was studied in order to determine the effect of serum complement on the particle phagocytosis by the organs of the reticulo-endothelial system (RES).
METHODS: PMMA-nanoparticles were coated overnight with plasma proteins or serum complement, and injected into Wistar rats. The body distribution of nanoparticles was measured by means of scintillation counting of organ samples. In addition, proteins adsorbed to the particle surface were inactivated by heat treatment prior to injection, and the particle's distribution was measured as described above.
RESULTS: Whereas uncoated nanoparticles (control group) were mainly taken up by the Kupffer cells in the liver, incubation of the particles in plasma for 12 h followed by heat inactivation reduced the particle concentrations in the liver to merely 22% after 30 min. After 120 min, liver concentrations were still lower than the control group, and almost 30% of the administered dose of the heat-inactivated particle group was present in non-RES organs and tissues. Particles with non-inactivated complement were accumulated in the lung at concentrations of 29% after 30 min, which increased to 71% after 120 min, whereas those coated with inactivated complement reached lung concentrations above 70% already after 30 min.
CONCLUSIONS: Particles coated with plasma components are able to avoid uptake by the RES, especially after heat inactivation of the plasma components adsorbed. Adsorption and heat inactivation of complement proteins alone, however, does not have the same result as coating with plasma proteins followed by heat inactivation. Therefore, it is concluded that plasma components other than complement proteins take part in the process of RES activation and phagocytosis of injected nanoparticles.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8842044     DOI: 10.1023/a:1016010808522

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  12 in total

Review 1.  The cell biology and pathogenic role of pulmonary intravascular macrophages.

Authors:  A E Warner; J D Brain
Journal:  Am J Physiol       Date:  1990-02

2.  Cellular uptake of a fluid-phase marker by human neutrophils from solutions and liposomes.

Authors:  J F Scieszka; M J Cho
Journal:  Pharm Res       Date:  1988-06       Impact factor: 4.200

3.  Redistribution and elimination of intravenously injected latex particles in mice.

Authors:  L Adlersberg; J M Singer; E Ende
Journal:  J Reticuloendothel Soc       Date:  1969 Oct-Dec

4.  Distribution and elimination of poly(methyl-2-14C-methacrylate) nanoparticle radioactivity after injection in rats and mice.

Authors:  J Kreuter; U Täuber; V Illi
Journal:  J Pharm Sci       Date:  1979-11       Impact factor: 3.534

5.  Colloidal carriers for intravenous drug targeting: plasma protein adsorption patterns on surface-modified latex particles evaluated by two-dimensional polyacrylamide gel electrophoresis.

Authors:  T Blunk; D F Hochstrasser; J C Sanchez; B W Müller; R H Müller
Journal:  Electrophoresis       Date:  1993-12       Impact factor: 3.535

6.  Internalization of poly(D,L-lactic acid) nanoparticles by isolated human leukocytes and analysis of plasma proteins adsorbed onto the particles.

Authors:  J C Leroux; P Gravel; L Balant; B Volet; B M Anner; E Allémann; E Doelker; R Gurny
Journal:  J Biomed Mater Res       Date:  1994-04

7.  Methods for increasing the resolution of two-dimensional protein electrophoresis.

Authors:  D F Hochstrasser; M G Harrington; A C Hochstrasser; M J Miller; C R Merril
Journal:  Anal Biochem       Date:  1988-09       Impact factor: 3.365

8.  In vivo uptake of polyisobutyl cyanoacrylate nanoparticles by rat liver Kupffer, endothelial, and parenchymal cells.

Authors:  V Lenaerts; J F Nagelkerke; T J Van Berkel; P Couvreur; L Grislain; M Roland; P Speiser
Journal:  J Pharm Sci       Date:  1984-07       Impact factor: 3.534

9.  Interaction of serum components with poly(methylmethacrylate) nanoparticles and the resulting body distribution after intravenous injection in rats.

Authors:  G Borchard; J Kreuter
Journal:  J Drug Target       Date:  1993       Impact factor: 5.121

10.  Body distribution of 75Se-radiolabeled silica nanoparticles covalently coated with omega-functionalized surfactants after intravenous injection in rats.

Authors:  G Borchardt; S Brandriss; J Kreuter; S Margel
Journal:  J Drug Target       Date:  1994       Impact factor: 5.121

View more
  8 in total

1.  Complement Inhibitors Block Complement C3 Opsonization and Improve Targeting Selectivity of Nanoparticles in Blood.

Authors:  Hanmant Gaikwad; Yue Li; Geoffrey Gifford; Ernest Groman; Nirmal K Banda; Laura Saba; Robert Scheinman; Guankui Wang; Dmitri Simberg
Journal:  Bioconjug Chem       Date:  2020-06-29       Impact factor: 4.774

2.  Peptide-MHC-based nanomedicines for autoimmunity function as T-cell receptor microclustering devices.

Authors:  Santiswarup Singha; Kun Shao; Yang Yang; Xavier Clemente-Casares; Patricia Solé; Antonio Clemente; Jesús Blanco; Qin Dai; Fayi Song; Shang Wan Liu; Jun Yamanouchi; Channakeshava Sokke Umeshappa; Roopa Hebbandi Nanjundappa; Pascal Detampel; Matthias Amrein; César Fandos; Robert Tanguay; Susan Newbigging; Pau Serra; Anmar Khadra; Warren C W Chan; Pere Santamaria
Journal:  Nat Nanotechnol       Date:  2017-04-24       Impact factor: 39.213

3.  Modulatory Role of Surface Coating of Superparamagnetic Iron Oxide Nanoworms in Complement Opsonization and Leukocyte Uptake.

Authors:  Swetha Inturi; Guankui Wang; Fangfang Chen; Nirmal K Banda; V Michael Holers; LinPing Wu; Seyed Moein Moghimi; Dmitri Simberg
Journal:  ACS Nano       Date:  2015-10-21       Impact factor: 15.881

4.  Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo.

Authors:  Fangfang Chen; Guankui Wang; James I Griffin; Barbara Brenneman; Nirmal K Banda; V Michael Holers; Donald S Backos; LinPing Wu; Seyed Moein Moghimi; Dmitri Simberg
Journal:  Nat Nanotechnol       Date:  2016-12-19       Impact factor: 39.213

5.  Complement opsonization of nanoparticles: Differences between humans and preclinical species.

Authors:  Yue Li; Guankui Wang; Lynn Griffin; Nirmal K Banda; Laura M Saba; Ernest V Groman; Robert Scheinman; S Moein Moghimi; Dmitri Simberg
Journal:  J Control Release       Date:  2021-09-02       Impact factor: 11.467

6.  Preparation and characterization of innovative protein-coated poly(methylmethacrylate) core-shell nanoparticles for vaccine purposes.

Authors:  Rebecca Voltan; Arianna Castaldello; Egidio Brocca-Cofano; Giuseppe Altavilla; Antonella Caputo; Michele Laus; Katia Sparnacci; Barbara Ensoli; Silvia Spaccasassi; Marco Ballestri; Luisa Tondelli
Journal:  Pharm Res       Date:  2007-05-03       Impact factor: 4.200

7.  Activation of Human Complement System by Dextran-Coated Iron Oxide Nanoparticles Is Not Affected by Dextran/Fe Ratio, Hydroxyl Modifications, and Crosslinking.

Authors:  Guankui Wang; Fangfang Chen; Nirmal K Banda; V Michael Holers; LinPing Wu; S Moein Moghimi; Dmitri Simberg
Journal:  Front Immunol       Date:  2016-10-10       Impact factor: 7.561

Review 8.  Physiological and Pathological Factors Affecting Drug Delivery to the Brain by Nanoparticles.

Authors:  Yamir Islam; Andrew G Leach; Jayden Smith; Stefano Pluchino; Christopher R Coxon; Muttuswamy Sivakumaran; James Downing; Amos A Fatokun; Meritxell Teixidò; Touraj Ehtezazi
Journal:  Adv Sci (Weinh)       Date:  2021-03-15       Impact factor: 16.806

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.